COVID-19: collaboration will keep us ahead of the curve.
作者信息
Shamdasani Pallavi, Trubiano Jason A, Smibert Olivia C, Owen Claire E, Liew David F L
机构信息
Department of Rheumatology, Austin Health, Melbourne, Victoria, Australia.
COVID Unit, Department of Infectious Diseases, Austin Health, Melbourne, Victoria, Australia.
出版信息
Intern Med J. 2020 Jul;50(7):784-786. doi: 10.1111/imj.14888.
Abstract
摘要
相似文献
1
COVID-19: collaboration will keep us ahead of the curve.新冠疫情：合作将使我们走在前沿。
Intern Med J. 2020 Jul;50(7):784-786. doi: 10.1111/imj.14888.
2
Impaired pulmonary function in discharged patients with COVID-19: more work ahead.出院的 COVID-19 患者的肺功能受损：前路漫漫。
Eur Respir J. 2020 Jul 23;56(1). doi: 10.1183/13993003.02194-2020. Print 2020 Jul.
3
Covid-19: transforming healthcare will require collaboration and innovative policies.新冠疫情：变革医疗保健需要合作与创新政策。
BMJ. 2020 Jun 5;369:m2229. doi: 10.1136/bmj.m2229.
4
Flattening the curve of new publications on COVID-19.平缓新冠疫情相关新出版物的增长曲线。
J Epidemiol Community Health. 2020 Sep;74(9):766-767. doi: 10.1136/jech-2020-214617. Epub 2020 Jul 6.
5
Primary care networks: the impact of covid-19 and the challenges ahead.基层医疗网络：新冠疫情的影响及未来挑战
BMJ. 2020 Sep 3;370:m3353. doi: 10.1136/bmj.m3353.
6
New Coronavirus (SARS-CoV-2): advances to flatten the curve the prison population.新型冠状病毒（严重急性呼吸综合征冠状病毒2）：降低监狱人口感染曲线的进展。 （注：你提供的原文表述似乎不太准确或完整，正常语境下可能是关于控制监狱内新冠疫情传播以降低感染人数曲线等相关内容，但按字面准确翻译如上。）
Rev Soc Bras Med Trop. 2020;53:e20200219. doi: 10.1590/0037-8682-0219-2020. Epub 2020 May 20.
7
Improving Ventilator Rationing Through Collaboration With Experts on Resource Allocation.通过与资源分配专家合作改善呼吸机配给
JAMA Netw Open. 2020 Jun 1;3(6):e2012838. doi: 10.1001/jamanetworkopen.2020.12838.
8
Flattening the curve on Covid-19.平缓新冠疫情曲线。
Vet Rec. 2020 Jun 27;186(19):652. doi: 10.1136/vr.m2497.
9
Covid-19: a fork in the road ahead for general practice or a knife severing the road behind?新冠疫情：是全科医疗未来道路上的一个岔路口，还是切断其身后道路的一把利刃？
BMJ. 2020 Oct 30;371:m4231. doi: 10.1136/bmj.m4231.
10
Evaluation of SARS-CoV-2 in the female reproductive tract of COVID-19 patients: A prospective study.新冠病毒肺炎患者女性生殖道中严重急性呼吸综合征冠状病毒2的评估：一项前瞻性研究。
J Biol Regul Homeost Agents. 2020;34(5):1885-1888. doi: 10.23812/20-352-L.
本文引用的文献
1
COVID-19: Immunology and treatment options.新型冠状病毒肺炎：免疫学与治疗选择。
Clin Immunol. 2020 Jun;215:108448. doi: 10.1016/j.clim.2020.108448. Epub 2020 Apr 27.
2
Effective treatment of severe COVID-19 patients with tocilizumab.托珠单抗治疗重症 COVID-19 患者有效。
Proc Natl Acad Sci U S A. 2020 May 19;117(20):10970-10975. doi: 10.1073/pnas.2005615117. Epub 2020 Apr 29.
3
Advances in COVID-19: the virus, the pathogenesis, and evidence-based control and therapeutic strategies.COVID-19 的研究进展：病毒、发病机制以及基于证据的防控和治疗策略。
Front Med. 2020 Apr;14(2):117-125. doi: 10.1007/s11684-020-0773-x. Epub 2020 Apr 21.
4
On the Alert for Cytokine Storm: Immunopathology in COVID-19.警惕细胞因子风暴：COVID-19 的免疫病理学。
Arthritis Rheumatol. 2020 Jul;72(7):1059-1063. doi: 10.1002/art.41285. Epub 2020 May 10.
5
Pharmacologic Treatments for Coronavirus Disease 2019 (COVID-19): A Review.药物治疗 2019 冠状病毒病（COVID-19）：综述。
JAMA. 2020 May 12;323(18):1824-1836. doi: 10.1001/jama.2020.6019.
6
COVID-19: immunopathology and its implications for therapy.新型冠状病毒肺炎：免疫病理学及其治疗意义。
Nat Rev Immunol. 2020 May;20(5):269-270. doi: 10.1038/s41577-020-0308-3.
7
Clinical and immunological features of severe and moderate coronavirus disease 2019.新型冠状病毒病 2019 重症和中度患者的临床和免疫学特征。
J Clin Invest. 2020 May 1;130(5):2620-2629. doi: 10.1172/JCI137244.
8
SARS-CoV-2: a storm is raging.新型冠状病毒：风暴正在肆虐。
J Clin Invest. 2020 May 1;130(5):2202-2205. doi: 10.1172/JCI137647.
9
Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China.《武汉 2019 年新型冠状病毒感染的肺炎 138 例住院患者临床特征分析》
JAMA. 2020 Mar 17;323(11):1061-1069. doi: 10.1001/jama.2020.1585.
10
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.中国武汉地区 2019 年新型冠状病毒感染患者的临床特征。
Lancet. 2020 Feb 15;395(10223):497-506. doi: 10.1016/S0140-6736(20)30183-5. Epub 2020 Jan 24.
Zotero 插件